MedPath

Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.

Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck

Phase 2
Completed
Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
First Posted Date
2014-02-13
Last Posted Date
2015-10-08
Lead Sponsor
Sanofi
Target Recruit Count
35
Registration Number
NCT02061631

MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma

Phase 1
Completed
Conditions
Multiple Myeloma
Kahler Disease
Plasma-Cell Myeloma
Myelomatosis
Interventions
First Posted Date
2014-02-07
Last Posted Date
2019-12-11
Lead Sponsor
Jason Valent
Target Recruit Count
16
Registration Number
NCT02057640
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

Phase 2
Completed
Conditions
Advanced Solid Tumors
Interventions
First Posted Date
2014-02-07
Last Posted Date
2024-11-20
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
13
Registration Number
NCT02057380
Locations
🇺🇸

Site US10004, La Jolla, California, United States

🇺🇸

Site US10006, Tampa, Florida, United States

🇺🇸

Site US10002, Baltimore, Maryland, United States

and more 9 locations

Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children

Not Applicable
Conditions
Stridor
Interventions
First Posted Date
2014-02-06
Last Posted Date
2014-02-06
Lead Sponsor
Hospital Israelita Albert Einstein
Target Recruit Count
70
Registration Number
NCT02056379
Locations
🇧🇷

Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP), São Paulo, Brazil

Use of Dexamethasone in Uterine Artery Embolization

Not Applicable
Completed
Conditions
Adenomyosis
Uterine Myoma
Interventions
Drug: Normal saline
Drug: Dexamethasone
First Posted Date
2014-02-06
Last Posted Date
2015-04-17
Lead Sponsor
Severance Hospital
Target Recruit Count
64
Registration Number
NCT02056717
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide

Phase 2
Completed
Conditions
Relapsed or Refractory Multiple Myeloma
Interventions
Drug: Imnovid (pomalidomide)
Drug: Dexamethasone
Drug: Endoxan (Cyclophosphamide)
First Posted Date
2014-01-28
Last Posted Date
2017-10-30
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
60
Registration Number
NCT02046915
Locations
🇩🇪

University Hospital, Tuebingen, Germany

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Phase 2
Completed
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
First Posted Date
2014-01-28
Last Posted Date
2018-12-19
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
28
Registration Number
NCT02047253
Locations
🇺🇸

University of Tulane, New Orleans, Louisiana, United States

🇺🇸

Birmingham VA Medical Center, Birmingham, Alabama, United States

🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

and more 1 locations

A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)

Phase 1
Terminated
Conditions
Multiple Myeloma
Interventions
First Posted Date
2014-01-15
Last Posted Date
2021-04-08
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
77
Registration Number
NCT02036502

Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

Phase 3
Completed
Conditions
Post Ocular Surgical Inflammation and Pain
Interventions
Drug: Dexamethasone
Drug: Punctum Plug
First Posted Date
2014-01-13
Last Posted Date
2020-01-31
Lead Sponsor
Ocular Therapeutix, Inc.
Target Recruit Count
247
Registration Number
NCT02034019
Locations
🇺🇸

Texan Eye / Keystone Research, Ltd., Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath